window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : May 1, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

clinical development

  • Artificial Intelligence,Clinical Development,Clinical Trials,Technology and platforms

    Evinova and Bristol Myers Squibb collaborate on AI-driven clinical trial optimisation

    Evinova and Bristol Myers Squibb have entered a strategic collaboration [...]

    February 9, 2026
  • Biologics & Biosimilars,Clinical Development,Clinical Trials,Drug Development,Movers & Shakers,Orthapaedics,Rare Diseases

    Levicept appoints James Sandy as chief development officer to advance LEVI-04 for osteoarthritis

    Levicept has strengthened its executive team with the appointment of [...]

    February 4, 2026
  • Biotech,Cell & Gene Therapy,Drug Development,Healthcare leadership,Immunology

    TECregen appoints Dr Klaas Zuideveld as CEO to advance thymus regeneration platform

    TECregen has appointed Dr Klaas Zuideveld as chief executive officer [...]

    January 29, 2026
  • Clinical Development,Clinical Trials,Healthcare leadership,Movers & Shakers,Oncology,Patient Centricity

    START appoints Dr Navid Hafez as director of clinical research at new Los Angeles site

    The START Center for Cancer Research has appointed Dr Navid [...]

    January 27, 2026
  • Clinical Development,Clinical Trials,Immunology,Oncology,Pharmaceuticals and therapeutics

    Scancell clears FDA IND for iSCIB1+ registrational Phase 3 trial in advanced melanoma

    Scancell Holdings has announced that the U.S. Food and Drug [...]

    January 26, 2026
  • Biotech,Central Nervous System,Clinical Development,Clinical Trials,Pharmaceuticals and therapeutics,Rare Diseases

    Exciva raises €51 million Series B to fund phase 2 Alzheimer’s agitation trial

    Exciva GmbH has raised €51 million ($59m) in a Series [...]

    January 20, 2026
  • Artificial Intelligence,Biotech,Clinical Development,Clinical studies,Drug Development,Partnerships & Funding,Pharmaceuticals and therapeutics,Research & Development

    Immunai partners with Bristol Myers Squibb to apply immune system AI in clinical development

    Artificial Intelligence, Biotech, Clinical Development, Clinical studies, Drug Development, Partnerships [...]

    January 16, 2026
  • Biotech,Clinical Development,Healthcare leadership,Movers & Shakers

    Novotech appoints Anand Tharmaratnam as CEO

    Novotech has appointed Anand Tharmaratnam as chief executive officer, following [...]

    January 14, 2026
  • Biotech,Rare Diseases,Regulatory Affairs,Research & Development

    Minovia secures two new US patents for mitochondrial augmentation therapy platform

    Minovia Therapeutics has been granted two new US patents covering [...]

    January 13, 2026
  • Artificial Intelligence,Clinical Development,Clinical Trials,Data Management,Oncology,Research & Development

    Breast cancer tops list of most-studied diseases for fifth consecutive year, Phesi analysis finds

    Breast cancer remained the world’s most studied disease for the [...]

    January 9, 2026
Previous123Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Neomorph raises $100 million to advance NEO-811 Phase 1/2 cancer trial and molecular glue degrader pipeline
    Categories: Biotech, Clinical Trials, Drug discovery, Funding, Oncology, Partnerships & Funding, Pharmaceuticals and therapeutics, Research & Development, Technology and platforms
  • NICE expands Lokelma access for hyperkalaemia after draft recommendation
    Categories: Cardiovascular diseases, Chronic diseases, Market Access & Commercialization, Pharmaceuticals and therapeutics, Regulatory Affairs
  • Oncodesign expands ARRONAX deal to secure astatine-211 supply for radiotherapy research
    Categories: CDMOs & Manufacturing, Drug Development, European biotech, Logistics and distribution, Oncology, Partnerships & Funding, Supply Chain & Logistics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top